Dec 22, 2020
Pharming Announces Instructions for Exchanging Listed Ordinary Shares into Nasdaq Listed ADSs
Dec 22, 2020
Pharming Group announces ADSs admitted to trade on Nasdaq under the symbol "PHAR"
Dec 11, 2020
Pharming Reports on Extraordinary General Meeting of Shareholders
Dec 10, 2020
Pharming announces enrolment of first patient in US clinical trial for the treatment of COVID-19 with RUCONEST®
Nov 26, 2020
Pharming Group Publicly Files Registration Statement with the U.S. SEC to Facilitate Listing of ADSs Representing Ordinary Shares on Nasdaq Global Market
Nov 23, 2020
Juergen Ernst to retire from Pharming’s Board of Supervisory Directors after more than 11 years of distinguished service
Nov 19, 2020
Pharming announces commitment to build a new downstream manufacturing facility for RUCONEST®
Nov 09, 2020
Pharming appoints Jeroen Wakkerman as Chief Financial Officer
Oct 29, 2020
Pharming Group reports financial results for the first nine months of 2020
Oct 29, 2020
Pharming convenes Extraordinary General Meeting of shareholders
Displaying 1 - 10 of 29